On May 2, Nasdaq Notified NeuBase Therapeutics Inc That It Has Not Regained Compliance With Minimum Bid Price Requirement
On May 2, Nasdaq Notified NeuBase Therapeutics Inc That It Has Not Regained Compliance With Minimum Bid Price Requirement
5月2日，納斯達克通知NeuBase Therapeutics Inc尚未恢復遵守最低出價要求
On May 2, Nasdaq Notified NeuBase Therapeutics Inc That It Has Not Regained Compliance With Minimum Bid Price Requirement
5月2日，納斯達克通知NeuBase Therapeutics Inc尚未恢復遵守最低出價要求
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。